Investor News

Major shareholder SABIC has submitted two items for the agenda of the 26^th Annual General Meeting of shareholders which is scheduled to take place on April 7, 2021.

Clariant today announced that Conrad Keijzer will become Clariant’s new Chief Executive Officer. The Board of Directors has appointed him in its meeting yesterday evening. Conrad Keijzer will officially join the company as of January 1, 2021.

Clariant today announced its plans to adapt and refocus its organization post divestments. Clariant is transforming itself towards a higher-value specialty portfolio focusing on its core Business Areas: Care Chemicals, Catalysis and Natural Resources. The Group plans to rightsize regional organizations and service units in order to avoid remnant cost, thereby reducing complexity and increasing agility post the expiration of transitory service agreements following the closing of the divestitures.

Clariant today announced continuing operations sales of CHF 2.838 billion in the first nine months of 2020, compared to CHF 3.272 billion in the first nine months of 2019. This corresponds to a decrease of 6 % in local currency due to lower demand and 13 % in Swiss francs attributable to unfavorable currency developments.

Clariant announced first half year 2020 continuing operations sales of CHF 1.945 billion, compared to CHF 2.229 billion in the first half year 2019. This corresponds to a decrease of 5 % in local currency due to lower demand and 13 % in Swiss francs, attributable to unfavorable currency developments.

Clariant today announced that a fine of EUR 155.8 million was imposed as the European Commission has completed its investigation into the ethylene purchasing market.

Clariant today completed the sale of its entire Masterbatches business to PolyOne. The divestment marks an important milestone for Clariant’s transformation into a focused specialty chemicals company.

At today’s Annual General Meeting in Basel, the shareholders of Clariant Ltd, a focused, sustainable and innovative specialty chemical company, approved all agenda items and resolutions proposed by the Board of Directors. Due to the ongoing situation with regard to the spread of the coronavirus, shareholders could not attend this year’s Annual General Meeting in person and could exercise their rights exclusively via the independent proxy. Overall, 222 864 693 shares or around 67.14 % of the share capital of Clariant were represented. 

Due to the uncertain economic environment in light of the COVID-19 pandemic, Clariant's Board of Directors has confirmed the extraordinary distribution while proposing to withhold the distribution of the regular dividend.

Clariant today announces first quarter 2020 continuing operations sales of CHF 1.019 billion compared to CHF 1.164 billion in the first quarter of 2019.

The 25th Annual General Meeting (AGM) will take place on 29 June 2020, at 10:30 a.m. at the Congress Center Basel, Messeplatz 21, 4058 Basel, Switzerland.

Against the background of the worldwide spread of the coronavirus (SARS-CoV-2), the Swiss Federal Council implemented the COVID-19 Ordinance 2 which sets new rules for Annual General Meetings, effective March 16, at midnight. As a consequence of this declaration by the Swiss Federal Council, no shareholders are admitted to attend the General Meeting in person. However, the company may order that participants may exercise their rights exclusively in writing or in electronic form or through an independent proxy appointed by the company.

Clariant, a focused and innovative specialty chemical company, today published its Integrated Report 2019. It gives a detailed overview of the company’s multidimensional approach to value creation, covering both tangible and intangible, and financial and nonfinancial aspects of its business.

The Board of Directors decided to propose Mr. Nader Ibrahim Alwehibi and Mr. Thilo Mannhardt for election to the Board of Directors at its Annual General Meeting. The nominees will replace the current Board members Mr. Khaled Homza A. Nahas and Mr. Carlo G. Soave.

Clariant, a focused and innovative specialty chemical company, today announced full year 2019 continuing operations sales of CHF 4.399 billion, compared to CHF 4.404 billion in 2018. This corresponds to organic growth of 3 % in local currency and is a stable development in Swiss francs due to unfavorable currency fluctuations. The sales increase in local currency was driven by the Business Areas Catalysis and Natural Resources and was supported by both higher volumes and pricing.
For the full year, almost all regions contributed to the sales growth in local currency. Sales expansion was most pronounced in Latin America with 13 % growth, followed by an 8 % increase in Asia. Sales in the Middle East & Africa rose by a solid 3 % and Europe grew by 1 %. Only North America reported a contraction of 5 %.

Clariant, a focused and innovative specialty chemical company, today announced that Stephan Lynen will be appointed CFO as of April 1, 2020. The proven financial expert, currently Head of the Business Unit Additives, has been with the company for more than 20 years in various international general management and business roles. He will succeed Patrick Jany who decided to pursue a career opportunity outside of Clariant.